Literature DB >> 16156944

Australian women's needs and preferences for information about human papillomavirus in cervical screening.

Kirsten McCaffery1, Les Irwig.   

Abstract

OBJECTIVE: The role of human papillomavirus (HPV) in cervical cancer and developments in medical technology to prevent cervical cancer has changed information needs for women participating in cervical screening.
DESIGN: Qualitative face-to-face interviews were conducted with 19 women diagnosed with HPV infection on their Pap smear following routine cervical screening.
SETTING: Family planning clinics, general practice and specialist gynaecologist practices in Sydney and the surrounding area, Australia. MAIN OUTCOME MEASURES: Women's information needs, preferences and experiences of HPV diagnosis.
RESULTS: Women wanted further information on different HPV viral types, transmission, implications for sexual partners, prevalence, latency and regression of HPV, their management options and the implications of infection for cancer risk and fertility. Uncertainty about the key aspects of HPV, the style in which the clinician communicated the result and the mode of delivering the result (letter, telephone or consultation) influenced women's psychological response to the diagnosis of HPV. The delivery of results by letter alone was linked to considerable anxiety among the women interviewed. Women's experience of searching the Internet for further information about HPV was reported as difficult, anxiety provoking and contributing to the stigma of the infection because information was often located in the context of other sexually transmitted infections, with multiple sexual partners highlighted as a risk factor for infection.
CONCLUSION: Women participating in cervical screening need high-quality information about HPV and its role in cervical cancer prior to screening rather than afterwards, when they face an abnormal result. The clinician potentially plays an important role in moderating the effects of diagnosis through the manner and mode in which an HPV diagnosis is delivered. Revision of cervical screening policy and practice in light of the changes in the understanding of HPV is recommended.

Entities:  

Mesh:

Year:  2005        PMID: 16156944     DOI: 10.1258/0969141054855238

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  15 in total

1.  Characteristics Associated with HPV Diagnosis and Perceived Risk for Cervical Cancer Among Unmarried, Sexually Active College Women.

Authors:  Kelly L Wilson; Clayton J Cowart; Brittany L Rosen; Jairus C Pulczinski; Kayce D Solari; Marcia G Ory; Matthew Lee Smith
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

2.  Women's knowledge of HPV and their perceptions of physician educational efforts regarding HPV and cervical cancer.

Authors:  Megan Cermak; Randall Cottrell; Judy Murnan
Journal:  J Community Health       Date:  2010-06

3.  Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing.

Authors:  M Hendry; D Pasterfield; R Lewis; A Clements; S Damery; R D Neal; R Adke; D Weller; C Campbell; J Patnick; P Sasieni; C Hurt; S Wilson; C Wilkinson
Journal:  Br J Cancer       Date:  2012-06-14       Impact factor: 7.640

4.  Cervical cancer screening among university students in South Africa: a theory based study.

Authors:  Muhammad Ehsanu Hoque; Shanaz Ghuman; Roger Coopoosmay; Guido Van Hal
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

5.  The psychosexual impact of testing positive for high-risk cervical human papillomavirus (HPV): A systematic review.

Authors:  Kirsty F Bennett; Jo Waller; Mairead Ryan; Julia V Bailey; Laura A V Marlow
Journal:  Psychooncology       Date:  2019-08-21       Impact factor: 3.894

6.  Women's perspectives on illness when being screened for cervical cancer.

Authors:  Lise Hounsgaard; Mikaela Augustussen; Helle Møller; Stephen K Bradley; Suzanne Møller
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

7.  Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.

Authors:  Farhana Sultana; Dallas R English; Julie A Simpson; Julia M L Brotherton; Kelly Drennan; Robyn Mullins; Stella Heley; C David Wrede; Marion Saville; Dorota M Gertig
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430

Review 8.  The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs.

Authors:  Paolo Giorgi Rossi; Flavia Baldacchini; Guglielmo Ronco
Journal:  Front Oncol       Date:  2014-02-10       Impact factor: 6.244

9.  Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women.

Authors:  Leith León-Maldonado; Emily Wentzell; Brandon Brown; Betania Allen-Leigh; Leticia Torres-Ibarra; Jorge Salmerón; Deborah L Billings; James F Thrasher; Eduardo Lazcano-Ponce
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

Review 10.  Communication of cancer screening results by letter, telephone or in person: A mixed methods systematic review of the effect on attendee anxiety, understanding and preferences.

Authors:  Sian Williamson; Jacoby Patterson; Rebecca Crosby; Rebecca Johnson; Harbinder Sandhu; Samantha Johnson; Jacquie Jenkins; Margaret Casey; Olive Kearins; Sian Taylor-Phillips
Journal:  Prev Med Rep       Date:  2018-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.